521 related articles for article (PubMed ID: 33170151)
1. Single-cell transcriptome analysis demonstrates inter-patient and intra-tumor heterogeneity in primary and metastatic lung adenocarcinoma.
Liu Y; Ye G; Huang L; Zhang C; Sheng Y; Wu B; Han L; Wu C; Dong B; Qi Y
Aging (Albany NY); 2020 Nov; 12(21):21559-21581. PubMed ID: 33170151
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment.
Wei T; Song J; Liang K; Li L; Mo X; Huang Z; Chen G; Mao N; Yang J
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1049-1064. PubMed ID: 33387038
[TBL] [Abstract][Full Text] [Related]
3. Identification of RAC1 in promoting brain metastasis of lung adenocarcinoma using single-cell transcriptome sequencing.
Chen M; Li H; Xu X; Bao X; Xue L; Ai X; Xu J; Xu M; Shi Y; Zhen T; Li J; Yang Y; Ji Y; Fu Z; Xing K; Qing T; Wang Q; Zhong P; Zhu S
Cell Death Dis; 2023 May; 14(5):330. PubMed ID: 37202394
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a five-gene model to predict postoperative brain metastasis in operable lung adenocarcinoma.
Fu F; Zhang Y; Gao Z; Zhao Y; Wen Z; Han H; Li Y; Chen H
Int J Cancer; 2020 Jul; 147(2):584-592. PubMed ID: 32181877
[TBL] [Abstract][Full Text] [Related]
5. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
Yang Y; Wang M; Liu B
J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601
[TBL] [Abstract][Full Text] [Related]
6. Microdissection of the Bulk Transcriptome at Single-Cell Resolution Reveals Clinical Significance and Myeloid Cells Heterogeneity in Lung Adenocarcinoma.
Wu H; Qin J; Zhao Q; Lu L; Li C
Front Immunol; 2021; 12():723908. PubMed ID: 34659209
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic role of abnormal spindle‑like microcephaly‑associated protein in lung adenocarcinoma.
Wang J; Liang J; Li H; Han J; Jiang J; Li Y; Feng Z; Zhao R; Tian H
Int J Oncol; 2021 May; 58(5):. PubMed ID: 33786609
[TBL] [Abstract][Full Text] [Related]
8. Single-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells.
Kim KT; Lee HW; Lee HO; Kim SC; Seo YJ; Chung W; Eum HH; Nam DH; Kim J; Joo KM; Park WY
Genome Biol; 2015 Jun; 16(1):127. PubMed ID: 26084335
[TBL] [Abstract][Full Text] [Related]
9. Identification of theranostic factors for patients developing metastasis after surgery for early-stage lung adenocarcinoma.
Cheng WC; Chang CY; Lo CC; Hsieh CY; Kuo TT; Tseng GC; Wong SC; Chiang SF; Huang KC; Lai LC; Lu TP; Chao KSC; Sher YP
Theranostics; 2021; 11(8):3661-3675. PubMed ID: 33664854
[No Abstract] [Full Text] [Related]
10. Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinoma.
Nokin MJ; Darbo E; Travert C; Drogat B; Lacouture A; San José S; Cabrera N; Turcq B; Prouzet-Mauleon V; Falcone M; Villanueva A; Wang H; Herfs M; Mosteiro M; Jänne PA; Pujol JL; Maraver A; Barbacid M; Nadal E; Santamaría D; Ambrogio C
JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32759499
[TBL] [Abstract][Full Text] [Related]
11. Unique metastasis-associated lncRNA signature optimizes prediction of tumor relapse in lung adenocarcinoma.
Zhang X; Han J; Du L; Li X; Hao J; Wang L; Zheng G; Duan W; Xie Y; Zhao Y; Zhang X; Zou M; Wang C
Thorac Cancer; 2020 Mar; 11(3):728-737. PubMed ID: 31994347
[TBL] [Abstract][Full Text] [Related]
12. Coupled immune stratification and identification of therapeutic candidates in patients with lung adenocarcinoma.
Hu W; Wang G; Chen Y; Yarmus LB; Liu B; Wan Y
Aging (Albany NY); 2020 Aug; 12(16):16514-16538. PubMed ID: 32855362
[TBL] [Abstract][Full Text] [Related]
13. Single-cell RNA sequencing reveals heterogeneous tumor and immune cell populations in early-stage lung adenocarcinomas harboring EGFR mutations.
He D; Wang D; Lu P; Yang N; Xue Z; Zhu X; Zhang P; Fan G
Oncogene; 2021 Jan; 40(2):355-368. PubMed ID: 33144684
[TBL] [Abstract][Full Text] [Related]
14. A gene-based survival score for lung adenocarcinoma by multiple transcriptional datasets analysis.
Xiong Y; Lei J; Zhao J; Lu Q; Feng Y; Qiao T; Xin S; Han Y; Jiang T
BMC Cancer; 2020 Oct; 20(1):1046. PubMed ID: 33129284
[TBL] [Abstract][Full Text] [Related]
15. Circular RNA cMras inhibits lung adenocarcinoma progression via modulating miR-567/PTPRG regulatory pathway.
Yu C; Tian F; Liu J; Su M; Wu M; Zhu X; Qian W
Cell Prolif; 2019 May; 52(3):e12610. PubMed ID: 31012177
[TBL] [Abstract][Full Text] [Related]
16. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
[TBL] [Abstract][Full Text] [Related]
17. Circular RNA CDR1-AS contributes to pemetrexed and cisplatin chemoresistance through EGFR/PI3K signaling pathway in lung adenocarcinoma.
Mao Y; Xu R
Biomed Pharmacother; 2020 Mar; 123():109771. PubMed ID: 31881486
[TBL] [Abstract][Full Text] [Related]
18. A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies.
Li Y; Ge D; Gu J; Xu F; Zhu Q; Lu C
BMC Cancer; 2019 Sep; 19(1):886. PubMed ID: 31488089
[TBL] [Abstract][Full Text] [Related]
19. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma.
Gao Y; Luo L; Xie Y; Zhao Y; Yao J; Liu X
Mol Carcinog; 2020 May; 59(5):503-511. PubMed ID: 32133692
[TBL] [Abstract][Full Text] [Related]
20. KRT8 and KRT19, associated with EMT, are hypomethylated and overexpressed in lung adenocarcinoma and link to unfavorable prognosis.
Wang W; He J; Lu H; Kong Q; Lin S
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32519739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
